Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$0.47 +0.03 (+6.82%)
At close: Nov 9, 2026 · 4:00 PM EST

Scinai Immunotherapeutics (SCNI) Acquisitions (2026)

Updated

Scinai Immunotherapeutics' Acquisitions was $2.75 million in Q1 2026.

Analysis

Scinai Immunotherapeutics (SCNI) Acquisitions (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -17.15 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 10.59 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 19.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Scinai Immunotherapeutics 112,563.86 -8.15 Mn -1.25 Mn -5.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.50 Mn
Mar 31, 2026 2.75 Mn
API Access

Scinai Immunotherapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=SCNI&period=max&api_key=YOUR_API_KEY